Literature DB >> 24814347

The DNA-binding domain mediates both nuclear and cytosolic functions of p53.

Ariele Viacava Follis1, Fabien Llambi2, Li Ou1, Katherine Baran2, Douglas R Green2, Richard W Kriwacki3.   

Abstract

Under conditions of genotoxic stress, human p53 activates the apoptotic effectors BAX or BAK to result in mitochondrial outer-membrane permeabilization and apoptosis. Antiapoptotic BCL-2 family member BCL-xL opposes this activity by sequestering cytosolic p53 via association with its DNA-binding domain, an interaction enhanced by p53 tetramerization. Here we characterized the BCL-xL-p53 complex by NMR spectroscopy and modulated it through mutagenesis to determine the relative contributions of BCL-xL's interactions with p53 or other BCL-2 family proteins to the BCL-xL-dependent inhibition of UV irradiation-induced apoptosis. Under our experimental conditions, one-third of the antiapoptotic activity of BCL-xL was mediated by p53 sequestration and the remaining two-thirds through sequestration of proapoptotic BCL-2 family members. Our studies define the contributions of cytosolic p53 to UV irradiation-induced apoptosis and provide opportunities to explore its contributions to other p53-dependent apoptotic signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24814347      PMCID: PMC4134560          DOI: 10.1038/nsmb.2829

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  63 in total

1.  Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.

Authors:  A M Petros; D G Nettesheim; Y Wang; E T Olejniczak; R P Meadows; J Mack; K Swift; E D Matayoshi; H Zhang; C B Thompson; S W Fesik
Journal:  Protein Sci       Date:  2000-12       Impact factor: 6.725

2.  AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR.

Authors:  R A Laskowski; J A Rullmannn; M W MacArthur; R Kaptein; J M Thornton
Journal:  J Biomol NMR       Date:  1996-12       Impact factor: 2.835

3.  Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.

Authors:  P H Kussie; S Gorina; V Marechal; B Elenbaas; J Moreau; A J Levine; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

4.  Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2.

Authors:  S Gorina; N P Pavletich
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

Review 5.  Principles of protein-protein interactions.

Authors:  S Jones; J M Thornton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

6.  Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy.

Authors:  A N Bullock; J Henckel; A R Fersht
Journal:  Oncogene       Date:  2000-03-02       Impact factor: 9.867

7.  Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.

Authors:  A Inga; M A Resnick
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

8.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

Authors:  E H Cheng; M C Wei; S Weiler; R A Flavell; T W Mak; T Lindsten; S J Korsmeyer
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

9.  Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles.

Authors:  Hongwei Yao; Shuofu Mi; Weibin Gong; Jian Lin; Nuo Xu; Sarah Perrett; Bin Xia; Jinfeng Wang; Yingang Feng
Journal:  Biochemistry       Date:  2013-09-04       Impact factor: 3.162

10.  p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks.

Authors:  L B Schultz; N H Chehab; A Malikzay; T D Halazonetis
Journal:  J Cell Biol       Date:  2000-12-25       Impact factor: 10.539

View more
  42 in total

1.  Dynamics of the BH3-Only Protein Binding Interface of Bcl-xL.

Authors:  Xiaorong Liu; Alex Beugelsdijk; Jianhan Chen
Journal:  Biophys J       Date:  2015-09-01       Impact factor: 4.033

2.  Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.

Authors:  Fan He; Wade Borcherds; Tanjing Song; Xi Wei; Mousumi Das; Lihong Chen; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

3.  Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies.

Authors:  Anneleen Steels; Adriaan Verhelle; Olivier Zwaenepoel; Jan Gettemans
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

Review 4.  Dynamic Protein Interaction Networks and New Structural Paradigms in Signaling.

Authors:  Veronika Csizmok; Ariele Viacava Follis; Richard W Kriwacki; Julie D Forman-Kay
Journal:  Chem Rev       Date:  2016-02-29       Impact factor: 60.622

5.  Defining relative mutational difficulty to understand cancer formation.

Authors:  Lin Shan; Jiao Yu; Zhengjin He; Shishuang Chen; Mingxian Liu; Hongyu Ding; Liang Xu; Jie Zhao; Ailing Yang; Hai Jiang
Journal:  Cell Discov       Date:  2020-07-21       Impact factor: 10.849

6.  Cytoplasmic pro-apoptotic function of the tumor suppressor p73 is mediated through a modified mode of recognition of the anti-apoptotic regulator Bcl-XL.

Authors:  Mi-Kyung Yoon; Bu-Yeon Kim; Ji-Young Lee; Ji-Hyang Ha; Sung Ah Kim; Dong-Hwa Lee; Min-Sung Lee; Mi-Kyung Lee; Jin Sun Choi; Jin Hwa Cho; Jeong-Hoon Kim; Sunhong Kim; Jaewhan Song; Sung Goo Park; Byoung Chul Park; Kwang-Hee Bae; Sang Un Choi; Seung-Wook Chi
Journal:  J Biol Chem       Date:  2018-11-14       Impact factor: 5.157

7.  Investigating Conformational Dynamics and Allostery in the p53 DNA-Binding Domain Using Molecular Simulations.

Authors:  Elena Papaleo
Journal:  Methods Mol Biol       Date:  2021

Review 8.  p53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Authors:  Flore Kruiswijk; Christiaan F Labuschagne; Karen H Vousden
Journal:  Nat Rev Mol Cell Biol       Date:  2015-07       Impact factor: 94.444

Review 9.  MEG3: an Oncogenic Long Non-coding RNA in Different Cancers.

Authors:  Arwa Al-Rugeebah; Mohammed Alanazi; Narasimha Reddy Parine
Journal:  Pathol Oncol Res       Date:  2019-02-21       Impact factor: 3.201

10.  Enhanced Sampling of Intrinsic Structural Heterogeneity of the BH3-Only Protein Binding Interface of Bcl-xL.

Authors:  Xiaorong Liu; Zhiguang Jia; Jianhan Chen
Journal:  J Phys Chem B       Date:  2017-09-27       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.